489 related articles for article (PubMed ID: 28351708)
1. Biochemical and inhibition studies of glutamine synthetase from Leishmania donovani.
Kumar V; Yadav S; Soumya N; Kumar R; Babu NK; Singh S
Microb Pathog; 2017 Jun; 107():164-174. PubMed ID: 28351708
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a novel Ribose 5-phosphate isomerase B from Leishmania donovani.
Kaur PK; Dinesh N; Soumya N; Babu NK; Singh S
Biochem Biophys Res Commun; 2012 Apr; 421(1):51-6. PubMed ID: 22483752
[TBL] [Abstract][Full Text] [Related]
3. Structural exploration of glutamine synthetase from Leishmania donovani: Insights from in silico and in vitro analysis.
Kumar V; Sushma Sri N; Tripathi N; Sharma VK; Bharatam PV; Garg P; Singh S
Int J Biol Macromol; 2020 Mar; 146():860-874. PubMed ID: 31726137
[TBL] [Abstract][Full Text] [Related]
4. Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani.
Zhang WW; Charest H; Ghedin E; Matlashewski G
Mol Biochem Parasitol; 1996 Jun; 78(1-2):79-90. PubMed ID: 8813679
[TBL] [Abstract][Full Text] [Related]
5. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
[TBL] [Abstract][Full Text] [Related]
6. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of angiotensin converting enzyme related dipeptidylcarboxypeptidase from Leishmania donovani.
Goyal N; Duncan R; Selvapandiyan A; Debrabant A; Baig MS; Nakhasi HL
Mol Biochem Parasitol; 2006 Feb; 145(2):147-57. PubMed ID: 16257064
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.
Campos-Neto A; Soong L; Cordova JL; Sant'Angelo D; Skeiky YA; Ruddle NH; Reed SG; Janeway C; McMahon-Pratt D
J Exp Med; 1995 Nov; 182(5):1423-33. PubMed ID: 7595213
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.
Das A; Dasgupta A; Sharma S; Ghosh M; Sengupta T; Bandopadhyay S; Majumder HK
Nucleic Acids Res; 2001 May; 29(9):1844-51. PubMed ID: 11328867
[TBL] [Abstract][Full Text] [Related]
10. Genetic manipulation of Leishmania donovani threonyl tRNA synthetase facilitates its exploration as a potential therapeutic target.
Chadha S; Vijayan R; Gupta S; Munde M; Gourinath S; Madhubala R
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006575. PubMed ID: 29897900
[TBL] [Abstract][Full Text] [Related]
11. A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite.
Cui L; Rajasekariah GR; Martin SK
Gene; 2001 Dec; 280(1-2):153-62. PubMed ID: 11738828
[TBL] [Abstract][Full Text] [Related]
12. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
Mukherjee M; Bhattacharyya A; Duttagupta S
Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the gene encoding glyoxalase II from Leishmania donovani: a potential target for anti-parasite drugs.
Padmanabhan PK; Mukherjee A; Madhubala R
Biochem J; 2006 Jan; 393(Pt 1):227-34. PubMed ID: 16159313
[TBL] [Abstract][Full Text] [Related]
14. A bioinformatics approach to reanalyze the genome annotation of kinetoplastid protozoan parasite Leishmania donovani.
Pawar H; Kulkarni A; Dixit T; Chaphekar D; Patole MS
Genomics; 2014 Dec; 104(6 Pt B):554-61. PubMed ID: 25265881
[TBL] [Abstract][Full Text] [Related]
15. Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase from Leishmania donovani.
Allen TE; Hwang HY; Jardim A; Olafson R; Ullman B
Mol Biochem Parasitol; 1995 Jul; 73(1-2):133-43. PubMed ID: 8577321
[TBL] [Abstract][Full Text] [Related]
16. Deletion of Glutamine Synthetase Gene Disrupts the Survivability and Infectivity of
Kumar V; Ghosh S; Roy K; Pal C; Singh S
Front Cell Infect Microbiol; 2021; 11():622266. PubMed ID: 33732662
[TBL] [Abstract][Full Text] [Related]
17. Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.
Charest H; Matlashewski G
Mol Cell Biol; 1994 May; 14(5):2975-84. PubMed ID: 7545921
[TBL] [Abstract][Full Text] [Related]
18. The Leishmania donovani histidine acid ecto-phosphatase LdMAcP: insight into its structure and function.
Papadaki A; Politou AS; Smirlis D; Kotini MP; Kourou K; Papamarcaki T; Boleti H
Biochem J; 2015 May; 467(3):473-86. PubMed ID: 25695743
[TBL] [Abstract][Full Text] [Related]
19. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
[TBL] [Abstract][Full Text] [Related]
20. AMP-acetyl CoA synthetase from Leishmania donovani: identification and functional analysis of 'PX4GK' motif.
Soumya N; Kumar IS; Shivaprasad S; Gorakh LN; Dinesh N; Swamy KK; Singh S
Int J Biol Macromol; 2015 Apr; 75():364-72. PubMed ID: 25660655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
